Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscription Services
Promote Your Event
Submission Forms
Place an Ad
Weather
News
Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Items For Sale
Jobs
Pets
Auctions, Estate & Garage Sales
Place an ad
Services
Community
Personals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Karuna Therapeutics, Inc.
Karuna Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics Appoints Bill Meury as President and Chief Executive Officer
December 06, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics Reports Third Quarter 2022 Financial Results and Provides General Business Updates
November 03, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics to Present at the Jefferies 2022 London Healthcare Conference
November 01, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics to Present Data from the Phase 3 EMERGENT-2 Trial of KarXT in Schizophrenia at the 35th European College of Neuropsychopharmacology (ECNP) Congress
October 06, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics to Present at Upcoming Investor Conferences
September 01, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
August 12, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics Announces Pricing of Public Offering of Common Stock
August 09, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics Announces Proposed Public Offering of Common Stock
August 08, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics Reports Second Quarter 2022 Financial Results and Provides General Business Updates
August 08, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in Schizophrenia
August 08, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics to Present at Upcoming Investor Conferences
June 06, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics to Host Virtual Event Highlighting Clinical Program for Psychosis in Alzheimer’s Disease
May 18, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics Reports First Quarter 2022 Financial Results and Provides General Business Update
May 05, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics to Present at the 2022 RBC Capital Markets Global Healthcare Conference
May 03, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides General Business Update
February 24, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics to Present at the SVB Leerink 11th Annual Global Healthcare Conference
February 01, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 04, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics Appoints Charmaine Lykins as Chief Commercial Officer
November 29, 2021
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics and Zai Lab Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China
November 09, 2021
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics to Present at Upcoming Investor Conferences
November 08, 2021
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics Reports Third Quarter 2021 Financial Results and Provides General Business Update
November 04, 2021
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics to Present at 2021 Virtual Wells Fargo Healthcare Conference
September 01, 2021
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics to Present at the Citi 16th Annual BioPharma Virtual Conference
August 31, 2021
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics Reports Second Quarter 2021 Financial Results and Provides General Business Update
August 05, 2021
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics to Present at 2021 Wedbush PacGrow Healthcare Virtual Conference
August 03, 2021
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics Announces Results from Phase 1b Trial Evaluating the Safety and Tolerability of KarXT in Healthy Elderly Volunteers
June 23, 2021
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics to Present at Upcoming Investor Conferences
June 02, 2021
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics Reports First Quarter 2021 Financial Results and Provides General Business Update
May 06, 2021
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Karuna Therapeutics to Present at Upcoming Investor Conferences
May 04, 2021
From
Karuna Therapeutics, Inc.
Via
Business Wire
Tickers
KRTX
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.